Previous studies reported that patients with AD, in particular, apolipoprotein E (APOE) ε4 genotype carriers, have lower mean flow velocity (MFV) and higher PI of the MCA compared with age-matched non-demented individuals (Roher et al., 2011). This evidence concerns the gene APOE and Alzheimer disease.